British Biosimilars Association (BBA)

article

Biosimilars: the future of competition

27 April 2020 | By Nikki Withers (European Pharmaceutical Review)

Earlier this year, the British Biosimilars Association (BBA), the trade body representing the interests of biosimilar manufacturers, welcomed Dr Andrew Ellis as its new Chair. In this interview, Nikki Withers asks why biosimilars are so important for pharma and how he foresees the market evolving in the coming years.

news

Joint policy document shows the potential impact of Brexit

15 December 2017 | By Dr Zara Kassam (European Pharmaceutical Review)

The associations representing the European and British life science industry have launched a joint policy document on the potential impact of the United Kingdom’s exit from the European Union...